Kathleen S. Capps is Officer of ENANTA PHARMACEUTICALS INC. Currently has a direct ownership of 8,377 shares of ENTA, which is worth approximately $101,026. The most recent transaction as insider was on Dec 05, 2025, when has been sold 323 shares (Common Stock) at a price of $14.23 per share, resulting in proceeds of $4,596. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.38K
n/a 3M change
n/a 12M change
Total Value Held $101,026

Kathleen S. Capps Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 05 2025
SELL
Open market or private sale
$4,596 $14.23 p/Share
323 Reduced 3.71%
8,377 Common Stock
Dec 02 2025
SELL
Open market or private sale
$2,889 $13.96 p/Share
207 Reduced 2.32%
8,700 Common Stock
Dec 01 2025
SELL
Payment of exercise price or tax liability
$1,200 $14.12 p/Share
85 Reduced 0.95%
8,907 Common Stock
Nov 25 2025
BUY
Grant, award, or other acquisition
-
3,163 Added 26.02%
8,992 Common Stock
KSC

Kathleen S. Capps

Officer
Watertown, MA

Track Institutional and Insider Activities on ENTA

Follow ENANTA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTA shares.

Notify only if

Insider Trading

Get notified when an Enanta Pharmaceuticals Inc insider buys or sells ENTA shares.

Notify only if

News

Receive news related to ENANTA PHARMACEUTICALS INC

Track Activities on ENTA